Long non-coding RNA Bhmt-AS attenuates hepatic gluconeogenesis via modulation of Bhmt expression

Biochem Biophys Res Commun. 2019 Aug 13;516(1):215-221. doi: 10.1016/j.bbrc.2019.06.008. Epub 2019 Jun 14.

Abstract

Dysregulation of gluconeogenesis contributes to the pathogenesis of metabolic disease, such as type-2 diabetes. The role of long non-coding RNAs (lncRNAs) in the pathogenesis of diabetes has recently received increased attention. In the present study, we identified a novel lncRNA, betaine-homocysteine methyltransferase-antisense (Bhmt-AS), and examined its expression patterns under pathophysiological conditions. Our results revealed that the expression of Bhmt-AS was significantly increased in the livers of fasted and db/db mice and was induced by gluconeogenic hormonal stimuli. The Bhmt-AS was also shown to be a concordant regulator of Bhmt expression. Functionally, depletion of Bhmt-AS suppressed hepatic glucose production both in vivo and in vitro. Adenovirus-mediated hepatic knockdown of Bhmt-AS improved pyruvate tolerance, glucose tolerance, and insulin sensitivity. Furthermore, overexpression of Bhmt restored the decreased glucose production caused by knockdown of Bhmt-AS in primary hepatocytes. Taken together, we uncovered a novel antisense lncRNA (Bhmt-AS) that is co-expressed with Bhmt and concordantly and specifically regulates Bhmt expression both in vitro and in vivo to regulate hepatic gluconeogenesis.

Keywords: Bhmt; Bhmt-AS; Hepatic gluconeogenesis; Long non-coding RNA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Betaine-Homocysteine S-Methyltransferase / genetics*
  • Cells, Cultured
  • Gene Expression Regulation
  • Gene Knockdown Techniques
  • Gluconeogenesis*
  • Liver / metabolism*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • RNA, Long Noncoding / genetics*
  • Up-Regulation

Substances

  • RNA, Long Noncoding
  • Betaine-Homocysteine S-Methyltransferase
  • Bhmt protein, mouse